Overview
As a statistician originally trained in advanced method development for high-dimensional, low-sample-size data, my research bridges foundational statistical theory with complex clinical applications. My early work focused on high-throughput biological data—such as transcriptomics and metabolomics—where the number of variables vastly exceeds the sample size.
As a faculty member in the Weill Cornell Center for Global Health, I lead statistical methodology and data infrastructure for multiple NIH-funded studies across international partner sites in Tanzania, Haiti, and India—connecting rigorous quantitative methods and theory with clinical and translational research. Over time, this collaborative environment has shaped my career identity and expanded my methodological framework to address pressing, clinically oriented problems—ranging from infectious disease dynamics and cardiovascular risk modeling to complex longitudinal cohort analyses. Alongside my research, I train and mentor graduate students, postdoctoral fellows, and junior faculty in statistical and analytical methods across our international and domestic programs.
Highlights
- 1The Lancet. Global health · 2023
- 2The Journal of infectious diseases · 2024
- 3mBio · 2022
Publications
Funding
Active
13 grants- Co-IP01AI202868-06Determinants of TB Control, Relapse, and ReinfectionNational Institute of Allergy and Infectious Diseases · 2026–2031
- Co-IK24AI182638-01Schistosomiasis and Women's Reproductive HealthNational Institute of Allergy and Infectious Diseases · 2024–2029Career
- Co-IR01AI176943-01A1Impact of TB coinfection on HIV reservoirNational Institute of Allergy and Infectious Diseases · 2023–2028
- Co-IR01HD112141-03S1A type 2 hybrid effectiveness-implementation trial of Community Health Workers to improve screening for postpartum diabetes in urban slums of India - Foreign Subsite SupplementEunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028· 3 renewals
- KPR01HL143788-08S1A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2 - Foreign supplementNational Heart, Lung, and Blood Institute · 2018–2028· 3 renewals
- KPR21AI190640-01A1Salicylate-based Drugs as Adjuvants to Potentiate Bedaquiline's Anti-TB ActivityNational Institute of Allergy and Infectious Diseases · 2026–2028
- Co-IR01HL161673-01Engaging Religious Leaders to Reduce Blood Pressures in Tanzanian CommunitiesNational Heart, Lung, and Blood Institute · 2022–2027
- KP202409-72792Evaluating The Clinical Utility of A Novel RNA-Based Assay For Predicting TB Treatment Outcomes And Diagnosing Paucibacillary TBCRDF Global · 2024–2027
- Co-IR01HL160332-01HIV, Sleep, Nocturnal Non-dipping, and Cardiovascular Disease: a Tanzanian CohortNational Heart, Lung, and Blood Institute · 2021–2027
- KPP30AI168433-01Tri-Institutional Tuberculosis Research Advancement CenterNational Institute of Allergy and Infectious Diseases · 2022–2027
- Co-IR01AI168306-01Genital Immune, Mucosal, and Viral Effects of Female Genital Schistosomiasis in TanzaniaNational Institute of Allergy and Infectious Diseases · 2022–2027
- Co-IR01MH132440-04S1Omuyambi: Traditional Healer Support to Improve HIV Viral Suppression in Rural Uganda - Foreign Subsite SupplementNational Institute of Mental Health · 2023–2026· 2 renewals
Completed grants (5)
- Co-IR01MH118107-01Reducing Post-Hospital Mortality in HIV-Infected Adults in TanzaniaNational Institute of Mental Health · 2018–2025
- KPK24AI098627-06Global Health Research Training in HIV and TuberculosisNational Institute of Allergy and Infectious Diseases · 2012–2024· 2 renewals
- Sub-PIR01GM135926-04Learning Dynamics of Biological Processes from Time Course Omics DatasetsNational Institute of General Medical Sciences · 2019–2023 · via Cornell University - Ithaca
- KPR21TW011693-01Treatment of early hypertension in persons living with HIV for cardiovascular disease prevention in HaitiFogarty International Center · 2020–2023
- KPU19AI111143-06S1Tri-Institutional TB Research Unit: Persistence and LatencyNational Institute of Allergy and Infectious Diseases · 2020–2021
News mentions
- Diagnose to Cure: Developing RNA-based TB TestingApril 25, 2025
Weill Cornell Medicine investigators are developing a new test for TB that circumvents many of the current diagnostic challenges.
- Drug-Resistant Tuberculosis Responds Rapidly to Bedaquiline-based Second-Line TherapyFebruary 27, 2024
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO in Haiti.
- Working with Community Leaders Boosts Family Planning in TanzaniaNovember 16, 2023
Researchers at Weill Cornell Medicine found that partnering with local religious leaders boosted adoption of family planning methods in Tanzania.